Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
THC Stock Summary
Top 10 Correlated ETFs
THC
In the News
THC Financial details
Company Rating
Strong Buy
Market Cap
10.04B
Income
764M
Revenue
20.55B
Book val./share
15.93
Cash/share
12.16
Dividend
-
Dividend %
-
Employees
78.81K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
13.5
Forward P/E
-
PEG
-6.86
P/S
0.5
P/B
6.42
P/C
7.59
P/FCF
6.3
Quick Ratio
1.1
Current Ratio
1.51
Debt / Equity
9.38
LT Debt / Equity
2.68
-
-
EPS (TTM)
7.51
EPS next Y
-
EPS next Q
-
EPS this Y
-35.72%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
34.21%
Revenue last 5Y
2.15%
Revenue Q/Q
6.18%
EPS Q/Q
144.44%
-
-
-
-
SMA20
-1.98%
SMA50
13.79%
SMA100
54.69%
Inst Own
71.54%
Inst Trans
0.77%
ROA
3%
ROE
54%
ROC
0.11%
Gross Margin
64%
Oper. Margin
12%
Profit Margin
4%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
51.04-107.8
52W High
-13.71%
52W Low
+81.04%
RSI
31
Rel Volume
0.91
Avg Volume
1.15M
Volume
1.05M
Perf Week
-8.67%
Perf Month
-5.94%
Perf Quarter
72.87%
Perf Half Y
70.57%
-
-
-
-
Beta
2.136
-
-
Volatility
2.98%, 2.78%
Prev Close
-3.82%
Price
92.33
Change
-6.67%
THC Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 178.72 | 167.98 | 182.39 | 179.32 | 202.17 | |
Net income per share | 1.38 | 7.31 | 13.83 | 9.35 | 6.01 | |
Operating cash flow per share | 11.92 | 32.44 | 14.68 | 10.13 | 23.36 | |
Free cash flow per share | 5.44 | 27.3 | 8.52 | 3 | 15.97 | |
Cash per share | 2.53 | 23.29 | 22.13 | -6.17 | 12.08 | |
Book value per share | -3.59 | 0.27 | 9.62 | 10.68 | 15.82 | |
Tangible book value per share | -66.39 | -71.6 | -60.85 | -64.89 | -60.68 | |
Share holders equity per share | -3.59 | 0.27 | 9.62 | 10.68 | 15.82 | |
Interest debt per share | 152.19 | 159.24 | 155.09 | 149.34 | 157.29 | |
Market cap | 3.93B | 4.19B | 8.73B | 5.22B | 7.68B | |
Enterprise value | 18.42B | 17.47B | 22.01B | 19.44B | 22.67B | |
P/E ratio | 27.5 | 5.46 | 5.91 | 5.22 | 12.57 | |
Price to sales ratio | 0.21 | 0.24 | 0.45 | 0.27 | 0.37 | |
POCF ratio | 3.19 | 1.23 | 5.57 | 4.82 | 3.24 | |
PFCF ratio | 6.98 | 1.46 | 9.59 | 16.25 | 4.73 | |
P/B Ratio | -10.6 | 149.75 | 8.49 | 4.57 | 4.78 | |
PTB ratio | -10.6 | 149.75 | 8.49 | 4.57 | 4.78 | |
EV to sales | 1 | 0.99 | 1.13 | 1.01 | 1.1 | |
Enterprise value over EBITDA | 6.83 | 5.52 | 6.3 | 5.59 | 6.87 | |
EV to operating cash flow | 14.94 | 5.13 | 14.04 | 17.95 | 9.55 | |
EV to free cash flow | 32.72 | 6.09 | 24.19 | 60.55 | 13.97 | |
Earnings yield | 0.04 | 0.18 | 0.17 | 0.19 | 0.08 | |
Free cash flow yield | 0.14 | 0.68 | 0.1 | 0.06 | 0.21 | |
Debt to equity | -39.76 | 561.39 | 15.22 | 13.2 | 9.38 | |
Debt to assets | 0.63 | 0.58 | 0.57 | 0.56 | 0.53 | |
Net debt to EBITDA | 5.37 | 4.19 | 3.8 | 4.09 | 4.55 | |
Current ratio | 1.21 | 1.47 | 1.38 | 1.34 | 1.51 | |
Interest coverage | 1.54 | 1.98 | 3.11 | 2.62 | 2.69 | |
Income quality | 8.01 | 4.44 | 1.06 | 1.08 | 3.89 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.47 | 0.48 | 0.46 | 0.46 | 0.45 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.38 | 0.38 | 0.39 | 0.43 | 0.41 | |
Capex to operating cash flow | -0.54 | -0.16 | -0.42 | -0.7 | -0.32 | |
Capex to revenue | -0.04 | -0.03 | -0.03 | -0.04 | -0.04 | |
Capex to depreciation | -0.79 | -0.63 | -0.77 | -0.91 | -0.86 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 10.57 | 6.62 | 54.71 | 47.41 | 46.26 | |
ROIC | 0.05 | 0.13 | 0.13 | 0.1 | 0.11 | |
Return on tangible assets | 0.01 | 0.05 | 0.09 | 0.06 | 0.04 | |
Graham Net | -182.6 | -186.35 | -174.93 | -194.51 | -180.79 | |
Working capital | 876M | 2.3B | 1.97B | 1.51B | 2.41B | |
Tangible asset value | -6.87B | -7.52B | -6.5B | -6.94B | -6.17B | |
Net current asset value | -16.28B | -17.07B | -16.25B | -16.57B | -15.64B | |
Invested capital | -39.76 | 561.39 | 15.22 | 13.2 | 9.38 | |
Average receivables | 2.68B | 2.72B | 2.73B | 2.86B | 3.47B | |
Average payables | 1.21B | 1.21B | 1.25B | 1.4B | 1.46B | |
Average inventory | 307.5M | 339M | 376M | 394.5M | 408M | |
Days sales outstanding | 54.38 | 55.68 | 51.89 | 56.02 | 70.93 | |
Days payables outstanding | 143.76 | 147.74 | 142.58 | 167.72 | 28.36 | |
Days of inventory on hand | 37.01 | 45.04 | 42.12 | 45.16 | 8.28 | |
Receivables turnover | 6.71 | 6.56 | 7.03 | 6.52 | 5.15 | |
Payables turnover | 2.54 | 2.47 | 2.56 | 2.18 | 12.87 | |
Inventory turnover | 9.86 | 8.1 | 8.67 | 8.08 | 44.09 | |
ROE | -0.39 | 27.43 | 1.44 | 0.88 | 0.38 | |
Capex per share | -6.48 | -5.14 | -6.16 | -7.13 | -7.39 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 47.74 | 49.09 | 49.94 | 49.89 | 53.28 | |
Net income per share | 2.62 | 2.89 | 1.21 | 0.99 | 2.42 | |
Operating cash flow per share | 4.03 | 4.39 | 5.88 | 4.95 | 8.16 | |
Free cash flow per share | 1.25 | 2.09 | 4.58 | 3.22 | 6.1 | |
Cash per share | -6.31 | 7.49 | 9.18 | 10.38 | 12.16 | |
Book value per share | 10.93 | 12.05 | 13.2 | 14.42 | 15.93 | |
Tangible book value per share | -66.39 | -67.31 | -66.38 | -65.33 | -61.09 | |
Share holders equity per share | 10.93 | 12.05 | 13.2 | 14.42 | 15.93 | |
Interest debt per share | 146.37 | 149.62 | 150.09 | 150.37 | 151.68 | |
Market cap | 5.1B | 6.08B | 8.28B | 6.69B | 7.63B | |
Enterprise value | 19.32B | 20.4B | 22.4B | 20.68B | 22.61B | |
P/E ratio | 4.65 | 5.13 | 16.83 | 16.56 | 7.82 | |
Price to sales ratio | 1.02 | 1.21 | 1.63 | 1.32 | 1.42 | |
POCF ratio | 12.11 | 13.54 | 13.85 | 13.3 | 9.26 | |
PFCF ratio | 38.93 | 28.4 | 17.77 | 20.46 | 12.39 | |
P/B Ratio | 4.47 | 4.93 | 6.17 | 4.57 | 4.74 | |
PTB ratio | 4.47 | 4.93 | 6.17 | 4.57 | 4.74 | |
EV to sales | 3.87 | 4.06 | 4.41 | 4.08 | 4.2 | |
Enterprise value over EBITDA | 21.44 | 24.57 | 26.38 | 24.1 | 24.13 | |
EV to operating cash flow | 45.89 | 45.42 | 37.45 | 41.11 | 27.44 | |
EV to free cash flow | 147.48 | 95.3 | 48.06 | 63.24 | 36.71 | |
Earnings yield | 0.05 | 0.05 | 0.01 | 0.02 | 0.03 | |
Free cash flow yield | 0.03 | 0.04 | 0.06 | 0.05 | 0.08 | |
Debt to equity | 13.2 | 12.23 | 11.2 | 10.27 | 9.38 | |
Debt to assets | 0.56 | 0.56 | 0.55 | 0.55 | 0.53 | |
Net debt to EBITDA | 15.78 | 17.25 | 16.62 | 16.3 | 15.99 | |
Current ratio | 1.34 | 1.39 | 1.44 | 1.43 | 1.51 | |
Interest coverage | 2.45 | 2.73 | 2.67 | 2.5 | 3.18 | |
Income quality | 1.54 | 1.52 | 2.04 | 1.89 | 3.38 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.46 | 0.45 | 0.45 | 0.45 | 0.43 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.43 | 0.43 | 0.43 | 0.43 | 0.41 | |
Capex to operating cash flow | -0.69 | -0.52 | -0.22 | -0.35 | -0.25 | |
Capex to revenue | -0.06 | -0.05 | -0.03 | -0.03 | -0.04 | |
Capex to depreciation | -1.36 | -1.08 | -0.62 | -0.79 | -0.96 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 25.39 | 28.01 | 18.94 | 17.96 | 29.43 | |
ROIC | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | |
Return on tangible assets | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
Graham Net | -198.99 | -187.02 | -178.26 | -186.87 | -182.02 | |
Working capital | 1.51B | 1.65B | 1.84B | 1.93B | 2.41B | |
Tangible asset value | -6.94B | -6.89B | -6.76B | -6.63B | -6.17B | |
Net current asset value | -16.57B | -16.39B | -16.16B | -16.05B | -15.64B | |
Invested capital | 13.2 | 12.23 | 11.2 | 10.27 | 9.38 | |
Average receivables | 2.89B | 2.91B | 3.36B | 3.37B | 3.45B | |
Average payables | 1.37B | 1.35B | 1.22B | 1.22B | 1.31B | |
Average inventory | 399.5M | 406M | 405.5M | 408.5M | 412M | |
Days sales outstanding | 53.08 | 51.68 | 67.99 | 51.47 | 66.81 | |
Days payables outstanding | 157.4 | 120.4 | 125.86 | 123.35 | 27.2 | |
Days of inventory on hand | 42.38 | 41.11 | 40.81 | 42.38 | 7.94 | |
Receivables turnover | 1.7 | 1.74 | 1.32 | 1.75 | 1.35 | |
Payables turnover | 0.57 | 0.75 | 0.72 | 0.73 | 3.31 | |
Inventory turnover | 2.12 | 2.19 | 2.21 | 2.12 | 11.33 | |
ROE | 0.24 | 0.24 | 0.09 | 0.07 | 0.15 | |
Capex per share | -2.77 | -2.3 | -1.3 | -1.73 | -2.06 |
THC Frequently Asked Questions
What is Tenet Healthcare Corporation stock symbol ?
Tenet Healthcare Corporation is a US stock , located in Dallas of Tx and trading under the symbol THC
What is Tenet Healthcare Corporation stock quote today ?
Tenet Healthcare Corporation stock price is $92.33 today.
Is Tenet Healthcare Corporation stock public?
Yes, Tenet Healthcare Corporation is a publicly traded company.